The Valley Desk

NCT02484690 · Interventional trial

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Overall registry status Completed

Phase 2

Conditions Choroidal Neovascularization

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov